Back
Speaker illustration

undefined undefined undefined

Presentations

Left ventricular diastolic dysfunction in patients with paroxysmal atrial fibrillation

Event: Heart Failure 2019

Topic: Diastolic Ventricular Dysfunction

Session: Chronic Heart Failure – Pathophysiology and Mechanisms

Access
Like
Thumbnail

Circulating markers of immune inflammation have diagnostic value in acute coronary syndrome

Event: Acute Cardiovascular Care 2019

Topic: Inflammation

Session: Acute Coronary Syndromes - Pathophysiology and Mechanisms, Biomarkers , Treatment, Revascularization Poster Discussant

Access
Like
Thumbnail

Acute heart failure in hypertensive crisis: focus on left ventricular diastolic dysfunction

Event: Heart Failure 2018

Topic: Hypertension, Other

Session: Hypertension - Other

Access
Like
Thumbnail

Circulating markers of vascular wall lesion in asymptomatic atherosclerosis

Event: Frontiers in CardioVascular Biology 2018

Topic: Biomarkers

Session: Basic Science - Cardiac Diseases

Access
Like
Thumbnail

Evaluation of left ventricle diastolic dysfunction in the manifestation of acute heart failure in acute coronary syndrome.

Event: Acute Cardiovascular Care 2018

Topic: Acute Coronary Syndromes: Diagnostic Methods, Other

Session: General Acute Coronary Sydrome

Access
Like
Thumbnail

Immune-mediated inflammation and acute left ventricular failure in myocardial infarction

Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure

Topic: Diagnosis

Session: Acute heart failure

Access
Like
Thumbnail

Circulating markers of endothelial dysfunction as a predictors of cardiovascular events

Event: EuroPrevent 2017

Topic: Risk factors and risk prediction

Session: Risk factors: others_Part 3

Access
Like
Thumbnail

The prognostic value of anti-connective tissue antibodies in coronary heart disease and asymptomatic atherosclerosis

Event: Frontiers in CardioVascular Biology 2016

Topic: Endothelium

Session: Endothelium

Access
Like
Thumbnail

Cardiovascular risk modifying with extra-low dose anticytokine drugs in rhematoid artritis

Event: Frontiers in CardioVascular Biology 2016

Topic: Cytokines and cellular inflammation

Session: Cytokines and cellular inflammation - Vascular

Access
Like
Thumbnail

Low-dose anti-cytokine treatment impacts on heart failure with preserved ejection fraction in active rheumatoid arthritis

Event: HEART FAILURE 2016

Topic: Chronic nursing care

Session: Chronic heart failure

Access
Like
Thumbnail

ESC 365 is supported by

novartis Explore sponsored resources